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Objective: The outcome of surgical correction of atrioventricular septal defect with double-orifice left atrioven-
tricular valve has improved in recent years but is still reported to be associated with high mortality and reoperation
rates. Controversy exists about the management of the accessory orifice. We evaluated our results with correction
of atrioventricular septal defect with double-orifice left atrioventricular valve.
Methods: Between 1975 and 2006, 21 patients underwent correction of atrioventricular septal defect with dou-
ble-orifice left atrioventricular valve. Clinical data were obtained by means of retrospectively reviewing inpatient
and outpatient medical records. To evaluate the influence of double-orifice left atrioventricular valve on mortality
and the need for reoperation, a comparison was made with 291 consecutive patients who, during the same period,
underwent correction of atrioventricular septal defect without double-orifice left atrioventricular valve.
Results:None of the 21 patientswith double-orifice left atrioventricular valve had undergone a previous operation.
The accessory orifice was managed with different techniques depending on the severity of the regurgitation. There
was no in-hospital mortality, and there were 3 late deaths. Seven patients required 12 reoperations, 7 for left atrio-
ventricular valve insufficiency. Double-orifice left atrioventricular valve had no influence on mortality but was
a significant predictor for reoperation compared with repair of atrioventricular septal defect without double-orifice
left atrioventricular valve. At the latest follow-up, all 18 survivors were in NewYork Heart Association functional
class _ without medication. Only 1 patient showed residual mild left atrioventricular valve insufficiency.
Conclusion:Atrioventricular septal defect with double-orifice left atrioventricular valve can be repaired with low
mortality. However, double-orifice left atrioventricular valve is a predictor for reoperation. The accessory orifice
is often competent and should then be left untouched. If regurgitation of the accessory orifice is present, this is best
managed with suture or patch closure.Results of surgical correction of atrioventricular septal defect
(AVSD) have improved in recent years. However, valve
anomalies and left atrioventricular valve (LAVV) regurgita-
tion remain risk factors for mortality and reoperation.1-3 Dou-
ble-orifice left atrioventricular valve (DO–LAVV) is an
uncommon but surgically important valve abnormality. It
can occur as an isolated malformation but is most often asso-
ciated with AVSD. Management of the accessory orifice is
controversial.Wepresent our 30-year experiencewith surgical
repair of AVSD with DO–LAVV using different strategies to
manage the accessory orifice.Weevaluated outcomesbycom-
paring the results of repair of AVSD with DO–LAVV with
those of repair of AVSD without DO–LAVV.
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Patient Population
Between January 1975 and May 2006, 312 consecutive patients under-
went surgical intervention for AVSD at our institution. Complete AVSD
was observed in 209 (67.0%) patients, partial AVSD was observed in 76
(24.4%) patients, and intermediate AVSD was observed in 27 (8.6%) pa-
tients. An intermediate form of AVSD was defined as having a ‘‘scooped
out’’ interventricular septum, with the atrioventricular (AV) valves being
connected to the top of the septum by fibrous tissue ‘‘curtains’’ and tendi-
nous chordae, consequently resulting in a small or absent ventricular septal
defect component. Twenty-one (6.7%) patients had AVSD with DO–
LAVV, of whom 9 had a complete AVSD, 9 had a partial AVSD, and 3
had an intermediate AVSD. In 17 patients DO–LAVV was diagnosed pre-
operatively by means of echocardiographic analysis, and in 4 patients it was
discovered at the time of the operation. Demographic and clinical character-
istics for patients with and without DO–LAVV are summarized in Table 1.
For the 21 patients with DO–LAVV, median age at the time of surgical
correction of AVSDwas 8.2 months (range, 1.4 months to 11.9 years). Thir-
teen repairs were performed in infants younger than 1 year, and 9 repairs
were performed in infants younger than 6 months. All patients underwent
primary repair.
Operative Technique
All corrections of AVSDwith DO–LAVV were performed by using car-
diopulmonary bypass with moderate hypothermia and cold crystalloid car-
dioplegia. In patients with a complete AVSD, a 2-patch method was used
with different patch materials (autologous, heterologous pericardium, orrdiovascular Surgery c Volume 138, Number 5 1167
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AVSD ¼ atrioventricular septal defect
DO–LAVV ¼ double-orifice left atrioventricular
valve
LAVV ¼ left atrioventricular valve
Dacron). In patients with a partial AVSD or intermediate AVSD, closure of
the atrial septal defect was performed with autologous or heterologous peri-
cardial patches. Closure of the cleft in the left AV valve was performed com-
pletely or partially when total closure would result in obstruction. The
accessory orifice was left intact when competent. One-stage repair was per-
formed in the 3 patients with associated coarctation. Intraoperative echocar-
diographic analysis was used routinely since 1999 in all patients. Before that
time, echocardiography was not available in the operation room.
Data Acquisition
Data on survival and need for reoperation were collected for all patients
with AVSD by retrospectively reviewing both inpatient and outpatient
medical records. In-hospital mortality was defined as death before hospital
discharge or within 30 days after the operation. The closing interval for
follow-up was from February 2006 to December 2006. For patients with
AVSD and DO–LAVV, preoperative echocardiographic reports, cardiac
catheterization reports, or both; operative notes; and the latest echocardio-
graphic reportswere also reviewed.Recent echocardiographicDoppler stud-
ies were present for all surviving patients with AVSD and DO–LAVV. The
study was approved by the ethics committee of our institution.
Statistical Analysis
The SPSS statistical software program for Windows (version 14.0.2;
SPSS, Inc, Chicago, Ill) was used to perform the data analysis. Data are ex-
pressed as medians and ranges or frequencies and percentages, where appro-
priate. Estimates of survival and freedom from reoperation were obtained by
using the Kaplan–Meier method. For comparison between repair of AVSD
with DO–LAVV and repair of AVSDwithout DO–LAVV, the log-rank test
was used.
RESULTS
Preoperative LAVV Function
For the 21 patients with DO–LAVV, LAVV function was
evaluated preoperatively by means of echocardiographic
analysis, angiographic analysis, or both depending on the
era of operation. In patients with complete AVSD (n ¼ 9),
LAVV regurgitation of the true orifice was mild in 4 pa-
tients, moderate in 4 patients, and severe in 1 patient. In pa-
tients with partial AVSD (n ¼ 9), it was mild in 1 patient,
moderate in 6 patients, and severe in 2 patients. In patients
with intermediate AVSD (n ¼ 3), regurgitation was mild
in 2 patients and severe in 1 patient. None of the patients
with AVSD with DO–LAVV had valvular stenosis.
Accessory Orifice Characteristics
The accessory orifice was either located in the posterior
bridging leaflet (sometimes close to the junction of the poste-
rior bridging leaflet and the mural leaflet; n ¼ 18) or in the
anterior bridging leaflet (sometimes close to the junction of1168 The Journal of Thoracic and Cardiovascular Suthe anterior bridging leaflet and the mural leaflet; n ¼ 3).
The true orifice and the accessory orificewere each supported
by their own tension apparatus. Depending on the location of
the accessory orifice, the chords of the true orifice and the ac-
cessory orifice might converge and insert into a posterior or
anterior papillary muscle. The chords of the accessory orifice
then usually formed a ‘‘parachute.’’ In 3 patients with partial
AVSD and an accessory orifice in the posterior bridging leaf-
let next to the mural leaflet, the mural leaflet was reported to
be less developed than normal. In 14 patients regurgitation of
the accessory orifice was observed (mild in 1 patient, moder-
ate in 8 patients, and severe in 5 patients; see Figure 1).
Surgical Procedure
Cleft. In patients with complete AVSD (n¼ 9), the cleft was
closed completely in 3 patients, partially in 5 patients, and not
closed in 1 patient. In patients with partial AVSD (n¼ 9), the
cleft was closed completely in 2 patients, partially in 5 pa-
tients, and not closed in 2 patients. In the 3 patients with in-
termediate AVSD, the cleft was closed partially in all. Cleft
closure was always performed with interrupted sutures.
Accessory orifice. In patients with regurgitation of the ac-
cessory orifice (n ¼ 14), the regurgitation of the accessory
orifice was repaired. Severe regurgitation of the accessory
orifice was repaired with sutures (n ¼ 1), patches (n ¼ 2),
or resection of the tissue bridge and division of the papillary
muscle of the accessory orifice (n ¼ 2). Moderate regurgita-
tion of the accessory orifice was repaired mostly with sutures
(n ¼ 7) and in 1 patient with a patch. In the single patient
with mild regurgitation of the accessory orifice, the acces-
sory orifice was repaired with sutures. In all 7 patients with-
out regurgitation of the accessory orifice, the accessory
orifice was left untouched. The AV valve was repaired as
a 3-leaflet valve.
Follow-up
Follow-up data were complete for all 21 patients with
DO–LAVV. Three patients without DO–LAVV were lost
to follow-up. The median follow-up period was 11.2 years
(range, 0.4–24.3 years) for patients with DO–LAVV and
TABLE 1. Patient characteristics
AVSD with
DO–LAVV (n ¼ 21)
AVSD without
DO–LAVV (n ¼ 291)
Median age (range) 8.2 mo (1.4 mo–11.9 y) 7.1 mo (0.5 mo–30.4 y)
Male sex 10 (47.6%) 142 (48.8%)
Down syndrome 9 (42.9%) 152 (52.2%)
Complete AVSD 9 (42.9%) 200 (68.7%)
Partial AVSD 9 (42.9%) 67 (23.0%)
Intermediate AVSD 3 (14.3%) 24 (8.2%)
Coarctation aortae 3 (14.3%) 8 (2.7%)
Tetralogy of Fallot 0 24 (8.2%)
LVOT obstruction 0 2 (0.7%)
AVSD, Atrioventricular septal defect; DO–LAVV, double-orifice left atrioventricular
valve; LVOT, left ventricular outflow tract.rgery c November 2009
Hoohenkerk et al Congenital Heart Disease
C
H
D10.0 years (range, 0–29.3 years) for patients without DO–
LAVV.
Mortality
Among the patients with DO–LAVV, there was no early
mortality. There were 3 late deaths. One patient died of late-
phase sepsis, 1 patient died of respiratory failure, and 1 patient
died of cardiac failure. Estimated overall survival rates were
89.9% at 5 years and 84% at 10 and 15 years (Figure 2).
For patients without DO–LAVV, the estimated survival rates
at 5, 10, and15yearswere90.6%, 90.6%, and88.9%, respec-
tively. The log-rank test showedno statistically significant dif-
ference in overall survival for patients with DO–LAVV
compared with patients without DO–LAVV (P ¼ .61).
Reoperation
Seven patients with DO–LAVV required 12 reoperations.
Two patients underwent 1 reoperation, and 5 patients under-
went 2 reoperations. The median interval to the first reopera-
tion was 1.0 year (range, 0.2–2.2 years). All first reoperations
occurred within 2.5 years after the initial repair. Details for
patients undergoing reoperation are noted in Table 2.
Of the patients undergoing reoperation, 1 patient had
complete AVSD, 3 patients had partial AVSD, and 3 pa-
tients had intermediate AVSD. Incompetence of the true or-
ifice was the most frequent indication for reoperation (7/12
reoperations). Other indications for reoperation were
LAVV stenosis (n ¼ 2), left ventricular outflow tract ob-
struction (n ¼ 2), and paravalvular leakage after valve re-
placement (n ¼ 1). All patients undergoing reoperations
had partial cleft closure at the primary procedure, with no
FIGURE 1. Location of the accessory orifice. ABL, Anterior bridging
leaflet; PBL, posterior bridging leaflet; ML, mural leaflet; AAO, accessory
orifice in the anterior bridging leaflet; PAO, accessory orifice in the posterior
bridging leaflet; TBATO, tissue bridge between the accessory orifice and
true orifices.The Journal of Thoracic and Cto mild residual regurgitation postoperatively and progres-
sive regurgitation at follow-up. Cox regression analysis
showed that cleft closure was not a risk factor for reoperation
(P¼ .460). Both patients with severe regurgitation of the ac-
cessory orifice who underwent a different type of repair of
the double orifice with resection of the tissue bridge and di-
vision of the papillary muscle of the accessory orifice re-
quired reoperation (patients 6 and 7, Table 2). In these
patients the LAVV was replaced at reoperation because of
degenerative changes. At the second reoperation for regurgi-
tation of the true orifice, repair was performed in 1 patient,
and replacement was performed in another patient. Two pa-
tients required pacemaker implantation after the second re-
operation because of a temporary AV block. There was no
mortality related to reoperation. The Kaplan–Meier curve
for freedom of reoperation is shown in Figure 3. Freedom
from reoperation was 62.6% at 5, 10, and 15 years. The in-
cidence of reoperation in the group with AVSD with DO–
LAVV was significantly higher than in the group with
AVSD without DO–LAVV (P¼ .022). For patients without
DO–LAVV, freedom from reoperation was 88.5%, 84.4%,
and 80.7% at 5, 10, and 15 years, respectively.
Clinical Condition
At the last follow-up, all 18 survivors were in New York
Heart Association functional class I without medication. All
patients were in sinus rhythm. The last echocardiographic
Doppler studies revealed mild residual left AV valve insuf-
ficiency to be present in 1 patient.
DISCUSSION
DO–LAVV is a rare but important anomaly and has been
found in association with bicuspid aortic valve, aortic coarc-
tation, and, most commonly, AVSD.4-7 Earlier studies re-
ported incidences of DO–LAVV of 2% to 8.6% among
FIGURE 2. Overall survival in patients with atrioventricular septal defect
with double orifice left atrioventricular valve (DO–LAVV; solid line) versus
patientswith atrioventricular septal defectwithoutDO–LAVV (dashed line).ardiovascular Surgery c Volume 138, Number 5 1169
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t.1170 The Journal of Thoracic and Cardiovascular Supatients with AVSD.5,8-16 In our patients we found an inci-
dence of 6.7%. AVSD with DO–LAVV might present in
a wide spectrum of varieties.17 A characteristic anatomic
feature of AVSD with DO–LAVV is convergent chordal
insertion instead of normal divergent insertion into 2 foci
of insertion. The chords of both the true orifice and the acces-
sory orifice insert into their own focus of insertion, with the
chords of the accessory orifice forming a ‘‘parachute.’’ Ac-
cording to the operation reports in our series, the accessory
orifices were located either in the posterior bridging leaflet
(sometimes very near the junction of the posterior bridging
leaflet and themural leaflet; n¼ 18) or in the anterior bridging
leaflet (sometimes very near the junction of the anterior
bridging leaflet and the mural leaflet; n ¼ 3). It has also
been reported by others that the location of the accessory or-
ifice was most often found in the posterior bridging leaflet.18
Two patients with severe regurgitation of the accessory
orifice had a different type of repair of the double orifice,
with resection of the tissue bridge and division of the papil-
lary muscle of the accessory orifice. These 2 patients needed
reoperations because of important regurgitation. At the time
of reoperation, secondary degenerative changes of the papil-
lary muscle made valve replacement necessary.
Other authors have also mentioned that division of the
bridging tissue might cause regurgitation, resulting in valve
replacement or operative death.19-21 The complexity makes
effective repair difficult and might contribute to postopera-
tive valve dysfunction, reoperation, and mortality. More-
over, accessory orifices are seldom more than mildly
incompetent. Therefore our current opinion is that the
best surgical results are obtained by saving the tissue
bridge and tension apparatus and repairing the AV valve
as a 3-leaflet valve.22 The accessory orifice is best left un-
touched. The accessory orifice is most often small in size
FIGURE 3. Freedom from reoperation in patients with atrioventricular
septal defect with double-orifice left atrioventricular valve (DO–LAVV;
solid line) versus patients with atrioventricular septal defect without DO–
LAVV (dashed line).rgery c November 2009
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orifice area.
Therefore a suture or patch closure is indicated in the rare
circumstances in which the accessory orifice is insufficient.
To prevent stenosis insufficiency of an incompetent acces-
sory orifice, one might consider using resection of secondary
chords or splitting of papillary muscles to increase leaflet
mobility and thus coaptation of the leaflets.
AVSDwith DO–LAVV has been considered in the past to
be a significant risk factor for mortality and reoperation. Re-
ported mortality rates show important differences ranging
from 20% to 50%.5,8,14-16 In our series of 21 patients, there
was no early mortality. There were 3 late deaths, of which 2
were noncardiac. AVSD with DO–LAVV had no influence
on mortality when compared with repair of AVSD without
DO–LAVV. However, the incidence of reoperations in pa-
tients with AVSD with DO–LAVV was significantly higher
than in the group of patients with AVSD without DO–
LAVV. The most likely explanation for reoperation in 2 pa-
tients with intermediate AVSD is the resection of the tissue
bridge between the 2 orifices and the division of the papillary
muscle, which had led to secondary degenerative changes
and valve incompetence.
Lie and colleagues19 reported that patients with intermedi-
ate AVSD and DO–LAVV had a poor prognosis compared
with those with a partial or complete defect. Lee and associ-
ates,7 in contrast, reported 2 reoperations in patients with par-
tial AVSD in a study of 25 patients with DO–LAVV. Nakano
and coworkers18 reported that DO–LAVV was a significant
predictor for reoperation in patients with partial AVSD. One
of the explanations in these studies was that the additional val-
vular and subvalvular abnormalities might contribute toworse
surgical results in patientswith partial AVSDand intermediate
AVSD with DO–LAVV. In our study 3 patients with partial
AVSD and DO–LAVV had a less developed mural leaflet.
In most cases the accessory orifice in patients with DO–
LAVV is competent, and therefore the focus should be di-
rected on the cleft between the bridging leaflets in the
LAVV. Surgical closure of the cleft in patients with
AVSD reduces the incidence of LAVV regurgitation, reop-
eration, and mortality. In patients with DO–LAVV, the cleft
is closed to such an extent that regurgitation is managed op-
timally without creating a valvular stenosis. In our study all
patients who required reoperation because of LAVV regur-
gitation had undergone partial cleft closure. Cleft closure,
though, was shown not to be a significant risk factor for re-
operation, but patient numbers were relatively small. There-
fore based on our experience we prefer to accept a mild
regurgitation rather than to create a significant stenosis.
The double-orifice malformation can be repaired with low
mortality but is a risk factor for reoperation. Most accessoryThe Journal of Thoracic and Corifices are competent and can be left untouched. If needed,
regurgitation of the accessory orifice is best managed with
suture or patch closure.
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